Hemab Therapeutics Holdings, Inc.

Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: COAG

Hemab Therapeutics Holdings, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker COAG.

Profile compiled from public records. Is this your company? Request a correction or update

Hemab Therapeutics Holdings at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Stock listingNasdaq: COAG

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK2114044

Frequently asked questions about Hemab Therapeutics Holdings

Where is Hemab Therapeutics Holdings headquartered?

Hemab Therapeutics Holdings, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Hemab Therapeutics Holdings do?

Hemab Therapeutics Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Hemab Therapeutics Holdings a public company?

Yes. Hemab Therapeutics Holdings, Inc. trades on Nasdaq under the ticker COAG.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences